BioMed Realty Introduces Its 2013 Online Annual Report

            BioMed Realty Introduces Its 2013 Online Annual Report

PR Newswire

SAN DIEGO, April 14, 2014

SAN DIEGO, April 14, 2014 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE:
BMR), the fastest growing and largest provider of life science real estate in
the United States, announced today that its 2013 Online Annual Report and
other proxy materials are now available at http://www.biomedrealty.com/13AR.

Offering a combination of interactive content and videos, the 2013 Online
Annual Report – Advantage BioMed Realty – examines the company's
accomplishments during the past year, during which its seasoned and tested
team:

  oGenerated record-setting leasing volume, total revenues and rental
    revenues;
  oExecuted its single largest portfolio investment by merging with Wexford
    Science & Technology; and
  oCompleted its largest single build-to-suit transaction for a 297,000
    square foot laboratory and office building at The Landmark at Eastview
    campus for Regeneron Pharmaceuticals.

Commenting on the 2013 Online Annual Report, BioMed Realty's Chief Financial
Officer, Greg N. Lubushkin, said, "As we approach our ten-year anniversary as
a publicly-traded REIT, we are pleased to present our annual report in an
online format for the sixth consecutive year. We invite visitors to explore
the site to learn more about BioMed Realty's successes in providing unmatched
expertise to our valued tenant relationships, capitalizing on strategic
opportunities for growth and delivering results for our investors and business
partners throughout 2013."

The site also includes downloadable operating and financial reports and
corporate information.

Along with improving investor communication through interactive videos and
easily accessible financial information, the 2013 Online Annual Report
supports the company's economic, social and environmental goals, and
exemplifies BioMed Realty's commitment to sustainability.

About BioMed Realty Trust

BioMed Realty, with its trusted expertise and valuable relationships, delivers
optimal real estate solutions for biotechnology and pharmaceutical companies,
scientific research institutions, government agencies and other entities
involved in the life science industry. BioMed Realty owns or has interests in
properties comprising approximately 17.3 million rentable square feet.
Additional information is available at www.biomedrealty.com. Follow us on
Twitter @biomedrealty.

This press release contains forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995 based on current
expectations, forecasts and assumptions that involve risks and uncertainties
that could cause actual outcomes and results to differ materially. These risks
and uncertainties include, without limitation: general risks affecting the
real estate industry (including, without limitation, the inability to enter
into or renew leases, dependence on tenants' financial condition, and
competition from other developers, owners and operators of real estate);
adverse economic or real estate developments in the life science industry or
the company's target markets; risks associated with the availability and terms
of financing, the use of debt to fund acquisitions, developments and other
investments, and the ability to refinance indebtedness as it comes due;
failure to maintain the company's investment grade credit ratings with the
ratings agencies; failure to manage effectively the company's growth and
expansion into new markets, or to complete or integrate acquisitions and
developments successfully; reductions in asset valuations and related
impairment charges; risks and uncertainties affecting property development and
construction; risks associated with tax credits, grants and other subsidies to
fund development activities; risks associated with downturns in foreign,
domestic and local economies, changes in interest rates and foreign currency
exchange rates, and volatility in the securities markets; ownership of
properties outside of the United States that subject the company to different
and potentially greater risks than those associated with the company's
domestic operations; risks associated with the company's investments in loans,
including borrower defaults and potential principal losses; potential
liability for uninsured losses and environmental contamination; risks
associated with the company's potential failure to qualify as a REIT under the
Internal Revenue Code of 1986, as amended, and possible adverse changes in tax
and environmental laws; and risks associated with the company's dependence on
key personnel whose continued service is not guaranteed. For a further list
and description of such risks and uncertainties, see the reports filed by the
company with the Securities and Exchange Commission, including the company's
most recent annual report on Form 10-K and quarterly reports on Form 10-Q. The
company disclaims any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise.

SOURCE BioMed Realty Trust, Inc.

Website: http://www.biomedrealty.com
Contact: Rick Howe, Senior Director, Corporate Communications, (858) 207-5859,
richard.howe@biomedrealty.com
 
Press spacebar to pause and continue. Press esc to stop.